Kaleb Tesfai

Title(s)	Clin Res Crd Asst, Medicine
School	Vc-health Sciences-schools
Address	9500 Gilman Drive # La Jolla CA 92093
vCard	Download vCard

Bibliographic

Publications

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.

Altmetrics Details

PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.

A Prospective Study on the Prevalence of MASLD in Patients With Type 2 Diabetes and Hyperferritinaemia. Aliment Pharmacol Ther. 2025 Feb; 61(3):456-464. Amangurbanova M, Huang DQ, Noureddin N, Tesfai K, Bettencourt R, Siddiqi H, Lopez SJ, Cervantes V, Madamba E, Loomba R. PMID: 39499168.

View in: PubMed Mentions: Fields:
Dru Drug Therapy Gas Gastroenterology Pha Pharmacology
Translation:Humans
Disparities for Hispanic Adults With Metabolic Dysfunction-associated Steatotic Liver Disease in the United States: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2025 Feb; 23(2):236-249. Tesfai K, Pace J, El-Newihi N, Martinez ME, Tincopa MA, Loomba R. PMID: 39025254.

View in: PubMed Mentions: Fields:
Gas Gastroenterology
The impact of genetic risk on the prevalence of advanced fibrosis and cirrhosis in prospectively assessed patients with type 2 diabetes. Aliment Pharmacol Ther. 2024 08; 60(3):369-377. Bridi L, Agrawal S, Tesfai K, Madamba E, Bettencourt R, Richards LM, Khera AV, Loomba R, Ajmera V. PMID: 38825972; PMCID: PMC11236495.

View in: PubMed Mentions: 2 Fields:
Dru Drug Therapy Gas Gastroenterology Pha Pharmacology
Translation:Humans
Integrating genetic and socioeconomic data to predict the progression of nonalcoholic fatty liver disease. Am J Biol Anthropol. 2024 08; 184(4):e24979. Rieman-Klingler MC, Jung J, Tesfai K, Loomba R, Non AL. PMID: 38778456.

View in: PubMed Mentions: Fields:
Ant Anthropology
Translation:Humans
Validation of AGA clinical care pathway and AASLD practice guidance for nonalcoholic fatty liver disease in a prospective cohort of patients with type 2 diabetes. Hepatology. 2024 05 01; 79(5):1098-1106. Ajmera V, Tesfai K, Sandoval E, Lopez S, Cervantes V, Madamba E, Bettencourt R, Manousou P, Richards L, Loomba R. PMID: 37862551; PMCID: PMC11023802.

View in: PubMed Mentions: 3 Fields:
Gas Gastroenterology
Translation:Humans
A prospective study on the prevalence of NAFLD, advanced fibrosis, cirrhosis and hepatocellular carcinoma in people with type 2 diabetes. J Hepatol. 2023 03; 78(3):471-478. Ajmera V, Cepin S, Tesfai K, Hofflich H, Cadman K, Lopez S, Madamba E, Bettencourt R, Richards L, Behling C, Sirlin CB, Loomba R. PMID: 36410554; PMCID: PMC9975077.

View in: PubMed Mentions: 59 Fields:
Gas Gastroenterology
Translation:Humans